Retracing our STEP towards a successful CTL-based HIV-1 vaccine.
作者信息
Yang Otto O
机构信息
Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
出版信息
Vaccine. 2008 Jun 13;26(25):3138-41. doi: 10.1016/j.vaccine.2008.02.027. Epub 2008 Feb 27.
Abstract
摘要
相似文献
1
Retracing our STEP towards a successful CTL-based HIV-1 vaccine.回顾我们迈向成功的基于细胞毒性T淋巴细胞（CTL）的HIV-1疫苗的历程。
Vaccine. 2008 Jun 13;26(25):3138-41. doi: 10.1016/j.vaccine.2008.02.027. Epub 2008 Feb 27.
2
Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever?迈向开发用于治疗HIV-1感染的治疗性疫苗：我们比以往任何时候都更接近了吗？
Expert Rev Vaccines. 2007 Jun;6(3):289-91. doi: 10.1586/14760584.6.3.289.
3
Construction of an artificial immunogen, a candidate DNA vaccine encoding multiple CTL epitopes of HIV-1.构建一种人工免疫原，一种编码HIV-1多个CTL表位的候选DNA疫苗。
Dokl Biochem Biophys. 2004 Mar-Apr;395:108-10. doi: 10.1023/b:dobi.0000025558.70018.4a.
4
Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime.在联合疫苗接种方案中，使用基因枪通过多表位有效诱导HIV特异性CTL。
Vaccine. 1999 Feb 12;17(6):589-96. doi: 10.1016/s0264-410x(98)00238-2.
5
Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".1型人类免疫缺陷病毒疫苗研发：细胞毒性T淋巴细胞平台的最新进展——“棘手的业务”
J Virol. 2008 Apr;82(7):3166-80. doi: 10.1128/JVI.01634-07. Epub 2007 Nov 7.
6
[Status and current strategies of HIV vaccine development].[HIV疫苗研发的现状与当前策略]
Internist (Berl). 2003 Jun;44(6):711-8. doi: 10.1007/s00108-003-0935-3.
7
Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.一种旨在诱导细胞毒性T淋巴细胞对HIV-1中多个保守表位产生反应的DNA疫苗的研发。
J Immunol. 2003 Nov 15;171(10):5611-23. doi: 10.4049/jimmunol.171.10.5611.
8
[Different systems of delivery of HIV-1 DNA vaccine encoding the multiepitope CTL-immunogene].[编码多表位CTL免疫基因的HIV-1 DNA疫苗的不同递送系统]
Vestn Ross Akad Med Nauk. 2005(1):41-4.
9
Progress toward an HIV vaccine.艾滋病疫苗的进展。
Annu Rev Med. 2005;56:213-23. doi: 10.1146/annurev.med.54.101601.152349.
10
Developing DNA vaccines against immunodeficiency viruses.开发针对免疫缺陷病毒的DNA疫苗。
Curr Top Microbiol Immunol. 1998;226:161-73. doi: 10.1007/978-3-642-80475-5_10.
引用本文的文献
1
Efficiency of recombinant bacille Calmette-Guérin in inducing humoral and cell mediated immunities against human immunodeficiency virus type 1 third variable domain in immunized mice.重组卡介苗在诱导免疫小鼠针对人免疫缺陷病毒 1 型第三可变区的体液和细胞介导免疫中的效率。
Yonsei Med J. 2011 Jan;52(1):173-80. doi: 10.3349/ymj.2011.52.1.173.
2
T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challenge.T 细胞疫苗效力的相关指标在经过异源猴免疫缺陷病毒攻击后的表现。
J Virol. 2010 May;84(9):4352-65. doi: 10.1128/JVI.02365-09. Epub 2010 Feb 17.
3
Candidate vaccine sequences to represent intra- and inter-clade HIV-1 variation.候选疫苗序列以代表 HIV-1 内部和跨群变异。
PLoS One. 2009 Oct 8;4(10):e7388. doi: 10.1371/journal.pone.0007388.
4
T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces.针对人类免疫缺陷病毒（具有千面之貌的病毒）的T细胞疫苗策略。
J Virol. 2009 Sep;83(17):8300-14. doi: 10.1128/JVI.00114-09. Epub 2009 May 13.
5
Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge.疫苗诱导的细胞反应在异源攻击后控制猿猴免疫缺陷病毒复制。
J Virol. 2009 Jul;83(13):6508-21. doi: 10.1128/JVI.00272-09. Epub 2009 Apr 29.
6
Pirate primates in uncharted waters: lymphocyte transfers in unrelated, MHC-matched macaques.未知水域中的“海盗”灵长类动物：无关的、MHC匹配的猕猴之间的淋巴细胞转移
Curr HIV Res. 2009 Jan;7(1):51-6. doi: 10.2174/157016209787048492.
7
Relevance of studying T cell responses in SIV-infected rhesus macaques.在感染猴免疫缺陷病毒（SIV）的恒河猴中研究T细胞反应的意义。
Trends Microbiol. 2008 Dec;16(12):605-11. doi: 10.1016/j.tim.2008.08.010. Epub 2008 Oct 27.
本文引用的文献
1
Cross-clade detection of HIV-1-specific cytotoxic T lymphocytes does not reflect cross-clade antiviral activity.HIV-1特异性细胞毒性T淋巴细胞的跨亚型检测并不反映跨亚型抗病毒活性。
J Infect Dis. 2008 Feb 1;197(3):390-7. doi: 10.1086/525281.
2
Recognition of escape variants in ELISPOT does not always predict CD8+ T-cell recognition of simian immunodeficiency virus-infected cells expressing the same variant sequences.在酶联免疫斑点试验（ELISPOT）中识别逃逸变异体并不总是能预测CD8 + T细胞对表达相同变异序列的感染猿猴免疫缺陷病毒的细胞的识别情况。
J Virol. 2008 Jan;82(1):575-81. doi: 10.1128/JVI.00275-07. Epub 2007 Oct 24.
3
Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection.慢性1型人类免疫缺陷病毒（HIV）感染期间直肠黏膜和外周血单个核细胞中的多功能HIV gag特异性CD8 + T细胞应答
J Virol. 2007 Jun;81(11):5460-71. doi: 10.1128/JVI.02535-06. Epub 2007 Mar 7.
4
Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells.细胞毒性T淋巴细胞清除病毒感染细胞的表位依赖性亲和力阈值
J Virol. 2007 May;81(10):4973-80. doi: 10.1128/JVI.02362-06. Epub 2007 Feb 28.
5
Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.CTL 应答在 HIV-1 感染早期的连续扩展与病毒逃逸有关。
PLoS One. 2007 Feb 21;2(2):e225. doi: 10.1371/journal.pone.0000225.
6
Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay.使用优化且经过验证的酶联免疫斑点试验在HIV血清阴性的临床试验参与者中检测HIV疫苗诱导的细胞介导免疫。
J Acquir Immune Defic Syndr. 2007 May 1;45(1):20-7. doi: 10.1097/QAI.0b013e3180377b5b.
7
Evaluation of cellular immune responses in subjects chronically infected with HIV type 1.对1型艾滋病毒慢性感染者细胞免疫反应的评估。
AIDS Res Hum Retroviruses. 2007 Jan;23(1):67-76. doi: 10.1089/aid.2006.0114.
8
Selection on the human immunodeficiency virus type 1 proteome following primary infection.初次感染后对1型人类免疫缺陷病毒蛋白质组的选择。
J Virol. 2006 Oct;80(19):9519-29. doi: 10.1128/JVI.00575-06.
9
Antigen dose governs the shaping of CTL repertoires in vitro and in vivo.抗原剂量在体外和体内决定细胞毒性T淋巴细胞库的形成。
Int Immunol. 2006 Mar;18(3):435-44. doi: 10.1093/intimm/dxh383. Epub 2006 Jan 23.
10
Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.从CD8 + T细胞反应中选择性逃逸是人类免疫缺陷病毒1型（HIV-1）序列多样性的主要驱动力，并揭示了对HIV-1进化的限制。
J Virol. 2005 Nov;79(21):13239-49. doi: 10.1128/JVI.79.21.13239-13249.2005.
Zotero 插件